Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
5/4/2023
CDE Publicizes the List of Reference Formulations for GQCE Studies (69...
5/4/2023
Roche Disposes China Rights of Rocephin to Hasten Biopharma
5/4/2023
AstraZeneca Places Bet on COPD as COVID Vaccine Sales Fade
5/3/2023
CDE Issues the Technical Guidelines for Clinical R&D of Anti-Tumor Pho...
5/3/2023
CDE Solicits Comments on Implementation Suggestions for ICH Guidelines...
5/3/2023
19 EU Member States Seek to Reduce Dependency on Chinese APIs
5/3/2023
China Emerges as New APAC Pharma R&D Engine (BioSpectrum Asia/Citeline...
5/3/2023
Getting Novel Drugs to China Through Special Zones (thepharmaletter)
5/3/2023
New Report: China Cancer Antibodies Market Trends & Clinical Trials In...
5/2/2023
CBMG and Janssen Enter License Deal to Develop and Commercialize anti...
5/2/2023
Shunxi Licences Cartherics's CAR-T Cell Therapy for Ovarian Cancer in ...
5/1/2023
Broad Economic Rebound Inspires Hope for Faster Recovery of Chinese Ph...
4/28/2023
AstraZeneca Eyes More China Deals After Signing Three Licensing Deals
4/28/2023
NMPA Announces OTC Switch of Four Rx Drug Products
4/28/2023
Central Government Initiates Campaign to Crackdown on BMI Related Frau...
4/28/2023
Drug R&D and Product Registration News Digest April 2023 (4)
4/28/2023
Financial-related Company News Digest (April 2023)
4/28/2023
Recent Executive Moves
4/27/2023
Zai Lab Announces Global Deal with MediLink for a Next Gen ADC Program...
4/27/2023
CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...
4/27/2023
CDE Issues the Technical Guidelines for Clinical Trials of Chronic Hep...
4/27/2023
Southeast Asia Is Becoming a Hot New Market for China's Innovative Dru...
4/26/2023
Why Rising Demand for Healthcare Is Creating Investment Opportunities ...
4/26/2023
CFDI Issues the Dossier Requirements for GLP Certification of Drug Non...
4/26/2023
CFDI Solicits Public Comments on the Inspection Points and Judgment Pr...
4/26/2023
CDE Solicits Comments on Draft Implementation Suggestions of ICH Guide...
4/26/2023
CDE Issues the Technical Guidelines for Clinical Trials of Active Immu...
4/26/2023
Fosun Reportedly Drops Plan to Sell Stake in Gland Pharma
4/25/2023
I-Mab Announces Positive Outcome in Arbitration Relating to Agreements...
4/25/2023
NMPA Announces Package Insert Revision of Additional Two Drug Products
Page:
48
/
719
Total number of articles:
21546
:
[First]
[<<]
[46]
[47]
[48]
[49]
[50]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit